| P2093 | author name string | Prowse CV | |
| P2860 | cites work | Leucodepletion of blood products by filtration | Q40552848 |
| | Preservation of red cell properties after virucidal phototreatment with dimethylmethylene blue | Q42989598 |
| | Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus | Q45759631 |
| | A phase I/IIA clinical study with a chimeric mouse-human monoclonal antibody to the V3 loop of human immunodeficiency virus type 1 gp120. | Q45781815 |
| | AAVant-garde gene therapy | Q45855547 |
| | Gene and cell transfer for specific immunotherapy | Q45888812 |
| | EBV specific CTL: a model for immune therapy | Q45888825 |
| | Ex vivo expansion of cord blood progenitors | Q47686617 |
| | Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. | Q50876391 |
| | The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation | Q58455856 |
| | Sheep cloned by nuclear transfer from a cultured cell line | Q28275874 |
| | Transfusion medicine. First of two parts--blood transfusion | Q28296931 |
| | Activation and adherence of lyophilized human platelets on canine vessel strips in the Baumgartner perfusion chamber | Q28297372 |
| | Platelet growth factors: potential impact on transfusion medicine | Q33328500 |
| | Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets | Q33496016 |
| | The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes | Q33499204 |
| | Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits | Q33504864 |
| | Cytokines to reduce platelet transfusions: non-TPO cytokines | Q33579136 |
| | Hematopoietic stem cell expansion | Q33579405 |
| | Gene transfer into human haematopoietic stem cells | Q33579418 |
| | Dendritic cells: therapeutic potentials | Q33579423 |
| | Making Landsteiner's discovery superfluous: safety and economic implications of a universal group O red blood cell supply | Q33581244 |
| | Choice of human plasma preparations for transfusion | Q33602543 |
| | Economic evaluations of technologies to minimize perioperative transfusion: a systematic review of published studies. International Study of Peri-operative Transfusion (ISPOT) investigators | Q33602558 |
| | A history of haemopoietic cell transplantation | Q33610841 |
| | Prevention of transfusion-transmitted cytomegalovirus infection | Q33650397 |
| | Humoral regulation of hematopoietic stem cells | Q33661785 |
| | Human albumin administration in critically ill patients: systematic review of randomised controlled trials | Q33817199 |
| | Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine | Q36864987 |
| P433 | issue | 4 | |
| P304 | page(s) | 287-299 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Transfusion Medicine | Q15758505 |
| P1476 | title | Alternatives to standard blood transfusion: availability and promise | |
| P478 | volume | 9 | |